Incidence of New Primary Melanomas After Diagnosis of Stage III and IV Melanoma

Lisa Zimmer; Lauren E. Haydu; Alexander M. Menzies; Richard A Scolyer; Richard Kefford; John F. Thompson; Dirk Schadendorf; Georgina V. Long

doi:10.1200/jco.2013.49.5572

Abstract

1 min read

Patients with stage III and stage IV melanoma remain at risk for development of further primary melanomas, particularly if they have a history of multiple primary melanomas before stage III or IV disease. The incidence rates are lower than those reported in patients receiving BRAF inhibitors. However, the results must be compared with caution because dermatologic assessment is more frequent in BRAF inhibitor trials.

Related publications

Article2015

Neoadjuvant BRAF (dabrafenib) and MEK (trametinib) inhibition for high-risk resectable stage III and IV melanoma.

Jennifer A. Wargo, Rodabe N. Amaria, Merrick I. Ross, Robyn P.M. Saw, Jeffrey E. Gershenwald, Patrick Hwu, Sapna P. Patel, Isabella Claudia Glitza, Adi Diab, Richard Kefford, Richard A Scolyer, Helen Rizos, John F. Thompson, Kerwin F. Shannon, Andrew J. Spillane, Matteo S. Carlino, Alex Guminski, Lauren Simpson, Michael A. Davies, Georgina V. Long

Article2021

Management of resected stage III/IV melanoma with adjuvant immunotherapy.

Rebecca Johnson, Victoria Atkinson, Prachi Bhave, Alison M. Weppler, Geoffrey Peters, Afaf Abed, Megan Lyle, Muhammad Adnan Khattak, Andrew Haydon, Matteo S. Carlino, Shahneen Sandhu, Georgina V. Long, Alexander M. Menzies

Article2023

Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study

Iman Osman, M. Berwick, InterMEL, Li Luo, Judy R. Rees, Sheri L. Holmen, Jennifer S. Ko, Kathleen Conway, Pauline Funchain, M.S. Ernstoff, Adam Z. Reynolds, Nancy E. Thomas, Marcus Bosenberg, Venkatraman Seshan, Arshi Arora, Tawny W. Boyce, Peter Ngo, Matthew Schwartz, C.L. Thompson, I. Gorlov, Shenying Fang, P.F. Kuan, Graham J. Mann, Irene Orlow, Eva Hernando, ,

Article2022

Landscape of mutations in early stage primary cutaneous melanoma: An <scp>InterMEL</scp> study

Li Luo, Ronglai Shen, Arshi Arora, Irene Orlow, Klaus J. Busam, Cecilia Lezcano, Tim K. Lee, Eva Hernando, Ivan Gorlov, Christopher I. Amos, Marc S. Ernstoff, Venkatraman Seshan, Anne Ε. Cust, James S. Wilmott, Richard A Scolyer, Graham J. Mann, Eduardo Nagore, Pauline Funchain, Jennifer S. Ko, Peter Ngo, Sharon N. Edmiston, Kathleen Conway, Paul B. Googe, David W. Ollila,

Letter2014

Reply to M. Perier-Muzet et al

Lisa Zimmer, Lauren E. Haydu, Alexander M. Menzies, Richard A Scolyer, Richard Kefford, John F. Thompson, Dirk Schadendorf, Georgina V. Long